BB Biotech AG
BION.SW
$0.34
Change (1 day)
$56.39
Year High
$40.14
Year Low
Categories
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
P/E ratio for BB Biotech AG (BION.SW)
P/E ratio as of 2023: -11.34
According to BB Biotech AG's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -11.34. At the end of 2022 the company had a P/E ratio of -8.49.
P/E ratio history for BB Biotech AG from 2003 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -11.34 |
| 2022 | -8.49 |
| 2021 | -10.55 |
| 2020 | 5.94 |
| 2019 | 5.42 |
| 2018 | -7.13 |
| 2017 | 5.20 |
| 2016 | -3.80 |
| 2015 | 5.00 |
| 2014 | 1.82 |
| 2013 | 1.72 |
| 2012 | 2.82 |
| 2011 | -13.63 |
| 2010 | -6.67 |
| 2009 | 34.65 |
| 2008 | 26.83 |
| 2007 | -6.86 |
| 2006 | 7.44 |
| 2005 | 6.10 |
| 2004 | 8.65 |
| 2003 | 9.12 |